(Q43907953)

English

Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis

scientific article published in March 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Tony Hayek

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Marielle Kaplan

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ayelet Raz

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Shlomo Keidar

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Raymond Coleman

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Michael Aviram

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

161

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

65-74

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Modified forms of low density lipoprotein and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

The "best" of cholesterols, the "worst" of cholesterols: a tale of two receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin, LDL peroxidation and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin-Converting Enzyme Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Development of a high renin model of hypertension in the cynomolgus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

A continuous spectrophotometric assay for angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Microsomal lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900621-9

7 January 2021

Identifiers

10.1016/S0021-9150(01)00621-9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43907953&oldid=2244167993"